Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
22 hedge funds and large institutions have $370K invested in Bio-Path Holdings Inc in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
592% more capital invested
Capital invested by funds: $53.5K → $370K (+$317K)
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
57% more funds holding
Funds holding: 14 → 22 (+8)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$221K |
| 2 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
+$13.9K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$11.4K |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$9.32K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$9.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$11K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.93K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.07K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$952 |
BPTH Hedge Fund Activity: Q4 2024 in Review
22 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2024, worth a combined $370K — up 592% from $53.5K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new BPTH positions and 2 closed out — a net gain of 8 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $221K. The largest seller was Virtu Financial, exiting entirely with an estimated $11K sold.
- 22 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2024, up from 14 in Q3 2024.
- Funds reported $370K of Bio-Path Holdings Inc stock for Q4 2024, up 592% quarter-over-quarter.
- 10 funds opened new Bio-Path Holdings Inc positions in Q4 2024 and 2 closed out, a net change of +8 holders.
- The largest Bio-Path Holdings Inc buyer in Q4 2024 was Armistice Capital, an estimated $221K added.
- The largest Bio-Path Holdings Inc seller in Q4 2024 was Virtu Financial, an estimated $11K sold.
Based on aggregated 13F filings for Q4 2024.